Compare Garudafood Putra Putri Jaya Tbk. (GOOD) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Garudafood Putra Putri Jaya Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Garudafood Putra Putri Jaya Tbk. trades at Rp316 (market cap 11.59T, 110.1K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Garudafood Putra Putri Jaya Tbk. is far larger — about 111× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| GOOD | SCPI | |
|---|---|---|
Market Cap | 11.59T | 104.4B |
Volume | 110.1K | — |
Lot | 1.1K | — |
Turnover | 34.47M | — |
Average Price | 313.08 | — |
Value | 34.47M | — |
Indicative Equilibrium Price | 316 | — |
Indicative Equilibrium Volume | 17 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Garudafood Putra Putri Jaya Tbk.
PT Garudafood Putra Putri Jaya (the Company) was established in Indonesia based on Notarial Deed No. 21 of Dra. Selawati Halim, S.H., dated August 24, 1994 under the name of PT Garuda Putra Putri Jaya. Based on Notarial Deed No. 12 of Popie Savitri Martosuhardjo Pharmanto, S.H., dated November 7, 2000, the Company merged with PT Tudung Putra Jaya and PT Garudafood Jaya and subsequentlychanged its name from PT Garuda Putra Putri Jaya to PT Garudafood Putra Putri Jaya based on Notarial Deed No. 44 of Popie Savitri Martosuhardjo Pharmanto, S.H., dated August 28, 2001
Read more on GOOD →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
